412 related articles for article (PubMed ID: 22186897)
21. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.
Krishnarjuna B; Andrew D; MacRaild CA; Morales RA; Beeson JG; Anders RF; Richards JS; Norton RS
Sci Rep; 2016 Feb; 6():20613. PubMed ID: 26865062
[TBL] [Abstract][Full Text] [Related]
22. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.
Trieu A; Kayala MA; Burk C; Molina DM; Freilich DA; Richie TL; Baldi P; Felgner PL; Doolan DL
Mol Cell Proteomics; 2011 Sep; 10(9):M111.007948. PubMed ID: 21628511
[TBL] [Abstract][Full Text] [Related]
23. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
[TBL] [Abstract][Full Text] [Related]
24. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
Front Immunol; 2021; 12():716305. PubMed ID: 34447381
[TBL] [Abstract][Full Text] [Related]
25. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
26. Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum.
Healer J; Thompson JK; Riglar DT; Wilson DW; Chiu YH; Miura K; Chen L; Hodder AN; Long CA; Hansen DS; Baum J; Cowman AF
PLoS One; 2013; 8(9):e72504. PubMed ID: 24039774
[TBL] [Abstract][Full Text] [Related]
27. PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47).
Nagaoka H; Sasaoka C; Yuguchi T; Kanoi BN; Ito D; Morita M; Udomsangpetch R; Sattabongkot J; Ishino T; Tsuboi T; Takashima E
Sci Rep; 2019 Apr; 9(1):5923. PubMed ID: 30976034
[TBL] [Abstract][Full Text] [Related]
28. A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates.
Douglas AD; Baldeviano GC; Jin J; Miura K; Diouf A; Zenonos ZA; Ventocilla JA; Silk SE; Marshall JM; Alanine DGW; Wang C; Edwards NJ; Leiva KP; Gomez-Puerta LA; Lucas CM; Wright GJ; Long CA; Royal JM; Draper SJ
Nat Commun; 2019 Apr; 10(1):1953. PubMed ID: 31028254
[TBL] [Abstract][Full Text] [Related]
29. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
[TBL] [Abstract][Full Text] [Related]
30. PfRON3 is an erythrocyte-binding protein and a potential blood-stage vaccine candidate antigen.
Zhao X; Chang Z; Tu Z; Yu S; Wei X; Zhou J; Lu H; Jiang N; Chen Q
Malar J; 2014 Dec; 13():490. PubMed ID: 25495792
[TBL] [Abstract][Full Text] [Related]
31. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
[TBL] [Abstract][Full Text] [Related]
32. Protein/AS01
Nielsen CM; Ogbe A; Pedroza-Pacheco I; Doeleman SE; Chen Y; Silk SE; Barrett JR; Elias SC; Miura K; Diouf A; Bardelli M; Dabbs RA; Barfod L; Long CA; Haynes BF; Payne RO; Minassian AM; Bradley T; Draper SJ; Borrow P
Cell Rep Med; 2021 Mar; 2(3):100207. PubMed ID: 33763653
[TBL] [Abstract][Full Text] [Related]
33. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
34. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
Partey FD; Castberg FC; Sarbah EW; Silk SE; Awandare GA; Draper SJ; Opoku N; Kweku M; Ofori MF; Hviid L; Barfod L
PLoS One; 2018; 13(6):e0198371. PubMed ID: 29883485
[TBL] [Abstract][Full Text] [Related]
36. Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
Biswas S; Choudhary P; Elias SC; Miura K; Milne KH; de Cassan SC; Collins KA; Halstead FD; Bliss CM; Ewer KJ; Osier FH; Hodgson SH; Duncan CJ; O'Hara GA; Long CA; Hill AV; Draper SJ
PLoS One; 2014; 9(9):e107903. PubMed ID: 25254500
[TBL] [Abstract][Full Text] [Related]
37. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies.
Pandey KC; Singh S; Pattnaik P; Pillai CR; Pillai U; Lynn A; Jain SK; Chitnis CE
Mol Biochem Parasitol; 2002 Aug; 123(1):23-33. PubMed ID: 12165386
[TBL] [Abstract][Full Text] [Related]
38. Anti-MSP11 IgG inhibits Plasmodium falciparum merozoite invasion into erythrocytes in vitro.
Tohmoto T; Takashima E; Takeo S; Morita M; Nagaoka H; Udomsangpetch R; Sattabongkot J; Ishino T; Torii M; Tsuboi T
Parasitol Int; 2019 Apr; 69():25-29. PubMed ID: 30385417
[TBL] [Abstract][Full Text] [Related]
39. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
[TBL] [Abstract][Full Text] [Related]
40. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.
Polley SD; Tetteh KK; Lloyd JM; Akpogheneta OJ; Greenwood BM; Bojang KA; Conway DJ
J Infect Dis; 2007 Jan; 195(2):279-87. PubMed ID: 17191173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
